allievex.com | Allievex | Developing Rare Disease

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.allievex.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	Allievex \| Developing Rare Disease
Description	Developing Therapeutics for Rare Pediatric Neurological Allievex is committed to developing first- and best-in-class therapies to benefit children with rare and devastating neurological
Keywords	N/A

Server Information

WebSite	allievex.com
Host IP	23.236.62.147
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

allievex.com Valuation

US$4,168,398

Last updated: 2023-05-03 01:40:17

allievex.com has Semrush global rank of 2,539,178. allievex.com has an estimated worth of US$ 4,168,398, based on its estimated Ads revenue. allievex.com receives approximately 480,969 unique visitors each day. Its web server is located in United States, with IP address 23.236.62.147. According to SiteAdvisor, allievex.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$4,168,398
Daily Ads Revenue	US$3,848
Monthly Ads Revenue	US$115,433
Yearly Ads Revenue	US$1,385,191
Daily Unique Visitors	32,065
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
allievex.com.	A	600	IP: 23.236.62.147
allievex.com.	NS	3600	NS Record: ns23.domaincontrol.com.
allievex.com.	NS	3600	NS Record: ns24.domaincontrol.com.
allievex.com.	MX	3600	MX Record: 0 allievex-com.mail.protection.outlook.com.
allievex.com.	TXT	3600	TXT Record: v=verifydomain MS=7618527
allievex.com.	TXT	3600	TXT Record: v=spf1 include:spf.protection.outlook.com -all

HtmlToTextCheckTime:2023-05-03 01:40:17

top of page Home Our Team Allievex Team Board of Directors Investors Our Focus Tralesinidase Alfa About Sanfilippo Syndrome Type B Pipeline News, Events & Publications News, Events & Publications Partner With Us Clinicians & Access Patients & Caregivers Contact Developing Therapeutics for Rare Pediatric Neurological Diseases OUR MISSION Allievex is committed to developing first- and best-in-class therapies to benefit children with rare and devastating neurological diseases. start Using intracerebroventricular administration of enzyme replacement therapy, we safely deliver our therapies where they’re needed most—to the cells of the central nervous system. Data from ongoing clinical trials for our first drug, tralesinidase alfa, provide preliminary, promising results for Sanfilippo syndrome type B patients. These findings offer exponential hope: an effective treatment for one rare pediatric neurological disease can uncover the keys to countless more. Learn more about our programs

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Mon, 25 Oct 2021 09:16:31 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.allievex.com/
strict-transport-security: max-age=120
Age: 63656
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=96
X-Seen-By: 6ivkWfREES4Y8b2pOpzk7CWfEJXUOf1J0Ah0dFlolkk=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkViyJt5juaDdUl23GREQFeDv,m0j2EEknGIVUW/liY8BLLl45Bek9v359fF7CbvAfPLwXK4CpcIIKXm19QkScmIm+,2d58ifebGbosy5xc+FRalt2Bfo/YGvPqhlrb9oOsfZx2/YK0ClhfWOPn/KUdW6O1tPQEFK7S6DF6004SOO1fxQ==,2UNV7KOq4oGjA5+PKsX47KDzNxuUDEAOOfLloEmnHbZYgeUJqUXtid+86vZww+nL
Cache-Control: no-cache
X-Wix-Request-Id: 1635153391.4921055493396623935
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Mon, 25 Oct 2021 09:16:31 GMT
content-type: text/html; charset=UTF-8
content-length: 467851
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"35018fb4f71f31fc9f40123016b86dc5"
content-language: en
strict-transport-security: max-age=120
age: 138952
set-cookie: ssr-caching=cache#desc=hit#varnish=hit#dc#desc=42; Max-Age=20; Expires=Sat, 23 Oct 2021 18:40:58 GMT
server-timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
x-seen-by: wmgbEcS9zOENaefw7bU4YVbPKomdLHJrTNNDJpklqig=,gv/XVF9HsGpk8A2KWukUzOwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVhvWjyoIilcz361CyhyEJkk,m0j2EEknGIVUW/liY8BLLl3+z1LPCVX20aGaUcDWZPwcm7On4dir39PTYYK13tG9,2d58ifebGbosy5xc+FRalvIP6sOVZraqlBjSeYOYaMhxeaZM/xm7OlFOkq9iOn/lusCem2qDW2ksmmawi3xOGw==,2UNV7KOq4oGjA5+PKsX47Br+ilU2OUaGN9cE2DqPolkfbJaKSXYQ/lskq2jK6SGP
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-wix-request-id: 1635153391.6343297583001415083
x-content-type-options: nosniff
set-cookie: TS01e85bed=01f0e93131562bd20c2b242009b84f033effe736bd744d21c3873e1764c185be304c18d174766eab5a051e5cdf4233db32463c91e0; Path=/;SameSite=none;Secure
server: Pepyaka/1.15.10

allievex.com Whois Information

Domain Name: ALLIEVEX.COM
Registry Domain ID: 2185508215_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2020-11-11T18:47:25Z
Creation Date: 2017-11-10T14:44:39Z
Registry Expiry Date: 2023-11-10T14:44:39Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS23.DOMAINCONTROL.COM
Name Server: NS24.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-13T13:07:40Z <<<

allievex.com valuation and analysis